X

Download Reversing Atherosclerosis with Aggressive Lipid Lowering PowerPoint Presentation

SlidesFinder-Advertising-Design.jpg

Login   OR  Register
X


Iframe embed code :



Presentation url :

Home / Health & Wellness / Health & Wellness Presentations / Reversing Atherosclerosis with Aggressive Lipid Lowering PowerPoint Presentation

Reversing Atherosclerosis with Aggressive Lipid Lowering PowerPoint Presentation

Ppt Presentation Embed Code   Zoom Ppt Presentation

PowerPoint is the world's most popular presentation software which can let you create professional Reversing Atherosclerosis with Aggressive Lipid Lowering powerpoint presentation easily and in no time. This helps you give your presentation on Reversing Atherosclerosis with Aggressive Lipid Lowering in a conference, a school lecture, a business proposal, in a webinar and business and professional representations.

The uploader spent his/her valuable time to create this Reversing Atherosclerosis with Aggressive Lipid Lowering powerpoint presentation slides, to share his/her useful content with the world. This ppt presentation uploaded by onlinesearch in Health & Wellness ppt presentation category is available for free download,and can be used according to your industries like finance, marketing, education, health and many more.

About This Presentation

Slide 1 - Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association Scientific Sessions 2003 Presented By Steven E. Nissen, M.D. REVERSAL Trial
Slide 2 - Aggressive lipid lowering strategy Atorvastatin (80 mg) n=253 Endpoints (follow-up 18 months): Primary – Percent change in atheroma volume on IVUS between baseline and 18 month follow-up Secondary – Absolute change in atheroma volume; change in the percent obstructive volume REVERSAL Trial AHA 2003, Orlando, FL 502 symptomatic coronary artery disease patients with elevated LDL Randomized, double-blind, multicenter Moderate lipid-lowering strategy Pravastatin (40 mg) n=249
Slide 3 - REVERSAL Trial LDL at follow-up p<0.001 AHA 2003, Orlando, FL mg/dL Total-cholesterol at follow-up p<0.001 mg/dL HDL at follow-up p=0.06 mg/dL
Slide 4 - REVERSAL Trial Change in atheroma volume p=0.02 for change between atorvastatin vs pravastatin Change in percent obstruction volume p=0.0002 for change between atorvastatin vs pravastatin AHA 2003, Orlando, FL
Slide 5 - REVERSAL Trial Percent Reduction in CRP p<0.001 AHA 2003, Orlando, FL
Slide 6 - REVERSAL Trial Among patients with symptomatic CAD and elevated LDL, use of an aggressive lipid-lowering strategy through treatment with 80-mg atorvastatin was associated with a reduction in percent change in atheroma volume compared with a more moderate lipid-lowering strategy through treatment with 40-mg pravastatin Primary endpoint used an IVUS endpoint and the trial was not designed to assess mortality or clinical events, and a much larger trial would be needed to assess superiority of one statin over another for these endpoints AHA/ACC guidelines currently recommend statin therapy (as a class) for reduction of LDL levels to <100 mg/dL